MacroGenics, Inc. (MGNX)
MacroGenics Market Cap : 186.54M for May 7, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.805B |
| Gilead Sciences, Inc. | 166.62B |
| SIGA Technologies, Inc. | 338.52M |
| BioLife Solutions, Inc. | 1.117B |
| ACADIA Pharmaceuticals, Inc. | 3.848B |
Market Cap Related Metrics
| PS Ratio | 1.240 |
| PEG Ratio | -0.2452 |
| Price to Book Value | 3.355 |
| Price | 2.935 |
| Earnings Yield | -40.33% |
| PEGY Ratio | -0.2452 |